Accurately identify the early stages of organ dysfunction, disease progression, treatment efficacy and discharge decisions in patients with infections, sepsis or septic shock
If you would like to request a test sample, please contact us...
Cut-off values for identifying sepsis severity in the Intensive Care Unit (ICU)...
View the latest publications and news concerning B·R·A·H·M·S MR-proADM...
The use of MR-proADM in assessing disease severity and treatment response in patients with sepsis and septic shock...Read news press release >
Join the call to EU action by the the Global Sepsis Alliance (GSA)...Find more events >
Antibiotic guidance using PCT, and treatment efficacy using MR-proADM...Learn more on B·R·A·H·M·S PCT >
Your browser does not support HTML5 video.
Watch Dr. Silvia Angeletti discuss how MR-proADM can change a patient’s diagnostic pathway from a laboratory perspective.
